PT UBC Medical Indonesia Tbk

Rp 122.00As of Sun 8 Nov 2026, 12:00 UTC
IDX:LABSHealthcare
Country Indonesia
PE (Fwd) •••
TSR 2Y CAGR (5.28%)
Div yield —
ROE 5.77%
Medical Devices
Beta (5Y) 0.05
PE TTM 54.68
TSR TTM (15.28%)
Mkt cap Rp 477.3B
ROIC 7.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Rp 119
(2.37%)
(84.66%)
Hold 6|0|1|9|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareRp
1.46
1.63
1.80
1.97
6.61%
7.81%
25.12%
32.95%
RevenueRp B
28.93
28.62
29.55
29.80
8.43%
7.47%
11.13%
6.85%
Peers (US$26.37M)
Cap (US$)
PE
26.43M
56.63x
Capital
TTM
5Y
10Y
Leveragex
0.435
0.109
0.105
EBIT/Intx
0.175
0.045
0.052
Own earn%
94.82
79.84
58.29
Sh yield%
21.24
18.81
18.67
Owners
Insiders/Inst%
14.73
41.17
Short interest%
5.54
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–20
$1 testx
—
Incr. ROIC%
2